APO Research, Inc.

APO RESEARCH · REPORT

Lower Extremity Exoskeleton Enhancement Device

Selected research

Market Analysis & Forecast

Global Lower Extremity Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032

Market perspective

The global Lower Extremity Exoskeleton Enhancement Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lower Extremity Exoskeleton Enhancement Device include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lower Extremity Exoskeleton Enhancement Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lower Extremity Exoskeleton Enhancement Device, also provides the sales of main regions and countries. Of the upcoming market potential for Lower Extremity Exoskeleton Enhancement Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lower Extremity Exoskeleton Enhancement Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lower Extremity Exoskeleton Enhancement Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lower Extremity Exoskeleton Enhancement Device sales, projected growth trends, production technology, application and end-user industry.

Lower Extremity Exoskeleton Enhancement Device Segment by Company

Alter G

B-TEMIA Inc.

Cyberdyne

Ekso Bionics

Hocoma

Interactive Motion Technologies

LockHeed Martin

Myomo

Panasonic

Parker Hannifin

ReWalk Robotics

US Bionics

Pharos Medical Technology

Mile Bot

Shenzhen Ruihan Medical Technology

Siyi Intelligence

Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type

Conventional Type

Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment

Industrial

Others

Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lower Extremity Exoskeleton Enhancement Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lower Extremity Exoskeleton Enhancement Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Smart Type Major Manufacturers Table 3. Conventional Type Major Manufacturers Table 4. Global Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Recovery Treatment Major Manufacturers Table 6. Industrial Major Manufacturers Table 7. Others Major Manufacturers Table 8. Lower Extremity Exoskeleton Enhancement Device Industry Trends Table 9. Lower Extremity Exoskeleton Enhancement Device Industry Drivers Table 10. Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 11. Lower Extremity Exoskeleton Enhancement Device Industry Restraints Table 12. Global Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2026) Table 16. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2027-2032) Table 17. Global Lower Extremity Exoskeleton Enhancement Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 18. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 19. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 20. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 21. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2027-2032) Table 22. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Lower Extremity Exoskeleton Enhancement Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021-2026) Table 26. Global Lower Extremity Exoskeleton Enhancement Device Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers, Product Type & Application Table 30. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Lower Extremity Exoskeleton Enhancement Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2026) Table 37. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2027-2032) Table 38. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type 2021 VS 2025 VS 2032 (Units) Table 39. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 40. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 41. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2026) Table 42. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2027-2032) Table 43. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2026) & (US$/Unit) Table 44. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2027-2032) & (US$/Unit) Table 45. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2026) Table 49. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2027-2032) Table 50. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application 2021 VS 2025 VS 2032 (Units) Table 51. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 52. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 53. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2026) Table 54. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2027-2032) Table 55. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2027-2032) & (US$/Unit) Table 57. Alter G Company Information Table 58. Alter G Business Overview Table 59. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 61. Alter G Recent Development Table 62. B-TEMIA Inc. Company Information Table 63. B-TEMIA Inc. Business Overview Table 64. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 66. B-TEMIA Inc. Recent Development Table 67. Cyberdyne Company Information Table 68. Cyberdyne Business Overview Table 69. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 71. Cyberdyne Recent Development Table 72. Ekso Bionics Company Information Table 73. Ekso Bionics Business Overview Table 74. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 76. Ekso Bionics Recent Development Table 77. Hocoma Company Information Table 78. Hocoma Business Overview Table 79. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 81. Hocoma Recent Development Table 82. Interactive Motion Technologies Company Information Table 83. Interactive Motion Technologies Business Overview Table 84. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 86. Interactive Motion Technologies Recent Development Table 87. LockHeed Martin Company Information Table 88. LockHeed Martin Business Overview Table 89. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 91. LockHeed Martin Recent Development Table 92. Myomo Company Information Table 93. Myomo Business Overview Table 94. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 96. Myomo Recent Development Table 97. Panasonic Company Information Table 98. Panasonic Business Overview Table 99. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 101. Panasonic Recent Development Table 102. Parker Hannifin Company Information Table 103. Parker Hannifin Business Overview Table 104. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 106. Parker Hannifin Recent Development Table 107. ReWalk Robotics Company Information Table 108. ReWalk Robotics Business Overview Table 109. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 111. ReWalk Robotics Recent Development Table 112. US Bionics Company Information Table 113. US Bionics Business Overview Table 114. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 116. US Bionics Recent Development Table 117. Pharos Medical Technology Company Information Table 118. Pharos Medical Technology Business Overview Table 119. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 121. Pharos Medical Technology Recent Development Table 122. Mile Bot Company Information Table 123. Mile Bot Business Overview Table 124. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 126. Mile Bot Recent Development Table 127. Shenzhen Ruihan Medical Technology Company Information Table 128. Shenzhen Ruihan Medical Technology Business Overview Table 129. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 131. Shenzhen Ruihan Medical Technology Recent Development Table 132. Siyi Intelligence Company Information Table 133. Siyi Intelligence Business Overview Table 134. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 136. Siyi Intelligence Recent Development Table 137. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 140. North America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 141. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (US$/Unit) Table 142. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (US$/Unit) Table 143. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 146. North America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 147. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (US$/Unit) Table 148. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (US$/Unit) Table 149. North America Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 153. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 154. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 155. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (US$/Unit) Table 156. North America Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (US$/Unit) Table 157. United States Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 158. Canada Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 159. Mexico Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 160. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 163. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 164. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (US$/Unit) Table 165. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (US$/Unit) Table 166. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 169. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 170. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (US$/Unit) Table 171. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 176. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 177. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 178. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (US$/Unit) Table 179. Europe Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Germany Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 181. France Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 182. U.K. Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 183. Italy Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 184. Russia Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 185. Spain Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 188. Sweden Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 189. Poland Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 190. China Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 191. China Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 192. China Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 193. China Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 194. China Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 197. China Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 198. China Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 199. China Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 200. China Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 205. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 206. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 211. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 212. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 218. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 219. Asia Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 220. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 223. South Korea Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 224. India Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 225. Australia Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 231. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 232. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 237. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 238. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 244. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 245. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 246. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Lower Extremity Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 249. Argentina Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 250. Chile Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 251. Colombia Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 252. Peru Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 254. Israel Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 255. UAE Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 256. Turkey Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 257. Iran Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 258. Egypt Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Lower Extremity Exoskeleton Enhancement Device Distributors List Table 262. Lower Extremity Exoskeleton Enhancement Device Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Lower Extremity Exoskeleton Enhancement Device Image Figure 2. Global Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Extremity Exoskeleton Enhancement Device Market Size Share 2021 VS 2025 VS 2032 Figure 4. Smart Type Image Figure 5. Conventional Type Image Figure 6. Global Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lower Extremity Exoskeleton Enhancement Device Market Size Share 2021 VS 2025 VS 2032 Figure 8. Recovery Treatment Image Figure 9. Industrial Image Figure 10. Others Image Figure 11. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 13. Global Lower Extremity Exoskeleton Enhancement Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032) Figure 16. Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 17. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 18. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Lower Extremity Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 20. Europe Lower Extremity Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 21. China Lower Extremity Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 22. Asia (Excluding China) Lower Extremity Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 23. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 24. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032) Figure 30. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 31. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032) Figure 33. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032) Figure 36. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 37. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032) Figure 39. North America Lower Extremity Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 40. North America Lower Extremity Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 41. North America Lower Extremity Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 42. North America Lower Extremity Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 43. North America Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 44. North America Lower Extremity Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 45. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 46. Europe Lower Extremity Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 47. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 48. Europe Lower Extremity Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 49. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 50. Europe Lower Extremity Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 51. China Lower Extremity Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 52. China Lower Extremity Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 53. China Lower Extremity Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 54. China Lower Extremity Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 55. Asia L

Scope & coverage.

Types
  • Smart Type
  • Conventional Type
Applications
  • Recovery Treatment
  • Industrial
  • Others
Companies covered
  • Alter G
  • B-TEMIA Inc.
  • Cyberdyne
  • Ekso Bionics
  • Hocoma
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Panasonic
  • Parker Hannifin
  • ReWalk Robotics
  • US Bionics
  • Pharos Medical Technology
  • Mile Bot
  • Shenzhen Ruihan Medical Technology
  • Siyi Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lower Extremity Exoskeleton Enhancement Device Market by Type
  3. 1.2.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Smart Type
  5. 1.2.3 Conventional Type
  6. 1.3 Lower Extremity Exoskeleton Enhancement Device Market by Application
  7. 1.3.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Recovery Treatment
  9. 1.3.3 Industrial
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lower Extremity Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region
  3. 3.2.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021-2026)
  5. 3.2.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2027-2032)
  6. 3.2.4 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region
  9. 3.4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026)
  11. 3.4.3 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032)
  12. 3.4.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Manufacturers
  2. 4.1.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Manufacturers
  6. 4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers, Product Type & Application
  13. 4.7 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lower Extremity Exoskeleton Enhancement Device Market CR5 and HHI
  16. 4.8.2 2025 Lower Extremity Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
5 Lower Extremity Exoskeleton Enhancement Device Market by Type
  1. 5.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type
  2. 5.1.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type
  6. 5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Type
6 Lower Extremity Exoskeleton Enhancement Device Market by Application
  1. 6.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application
  2. 6.1.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application
  6. 6.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Application
7 Company Profiles
  1. 7.1 Alter G
  2. 7.1.1 Alter G Company Information
  3. 7.1.2 Alter G Business Overview
  4. 7.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  6. 7.1.5 Alter G Recent Developments
  7. 7.2 B-TEMIA Inc.
  8. 7.2.1 B-TEMIA Inc. Company Information
  9. 7.2.2 B-TEMIA Inc. Business Overview
  10. 7.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  12. 7.2.5 B-TEMIA Inc. Recent Developments
  13. 7.3 Cyberdyne
  14. 7.3.1 Cyberdyne Company Information
  15. 7.3.2 Cyberdyne Business Overview
  16. 7.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  18. 7.3.5 Cyberdyne Recent Developments
  19. 7.4 Ekso Bionics
  20. 7.4.1 Ekso Bionics Company Information
  21. 7.4.2 Ekso Bionics Business Overview
  22. 7.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  24. 7.4.5 Ekso Bionics Recent Developments
  25. 7.5 Hocoma
  26. 7.5.1 Hocoma Company Information
  27. 7.5.2 Hocoma Business Overview
  28. 7.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  30. 7.5.5 Hocoma Recent Developments
  31. 7.6 Interactive Motion Technologies
  32. 7.6.1 Interactive Motion Technologies Company Information
  33. 7.6.2 Interactive Motion Technologies Business Overview
  34. 7.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  36. 7.6.5 Interactive Motion Technologies Recent Developments
  37. 7.7 LockHeed Martin
  38. 7.7.1 LockHeed Martin Company Information
  39. 7.7.2 LockHeed Martin Business Overview
  40. 7.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  42. 7.7.5 LockHeed Martin Recent Developments
  43. 7.8 Myomo
  44. 7.8.1 Myomo Company Information
  45. 7.8.2 Myomo Business Overview
  46. 7.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  48. 7.8.5 Myomo Recent Developments
  49. 7.9 Panasonic
  50. 7.9.1 Panasonic Company Information
  51. 7.9.2 Panasonic Business Overview
  52. 7.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  54. 7.9.5 Panasonic Recent Developments
  55. 7.10 Parker Hannifin
  56. 7.10.1 Parker Hannifin Company Information
  57. 7.10.2 Parker Hannifin Business Overview
  58. 7.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  60. 7.10.5 Parker Hannifin Recent Developments
  61. 7.11 ReWalk Robotics
  62. 7.11.1 ReWalk Robotics Company Information
  63. 7.11.2 ReWalk Robotics Business Overview
  64. 7.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  66. 7.11.5 ReWalk Robotics Recent Developments
  67. 7.12 US Bionics
  68. 7.12.1 US Bionics Company Information
  69. 7.12.2 US Bionics Business Overview
  70. 7.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  72. 7.12.5 US Bionics Recent Developments
  73. 7.13 Pharos Medical Technology
  74. 7.13.1 Pharos Medical Technology Company Information
  75. 7.13.2 Pharos Medical Technology Business Overview
  76. 7.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  78. 7.13.5 Pharos Medical Technology Recent Developments
  79. 7.14 Mile Bot
  80. 7.14.1 Mile Bot Company Information
  81. 7.14.2 Mile Bot Business Overview
  82. 7.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  84. 7.14.5 Mile Bot Recent Developments
  85. 7.15 Shenzhen Ruihan Medical Technology
  86. 7.15.1 Shenzhen Ruihan Medical Technology Company Information
  87. 7.15.2 Shenzhen Ruihan Medical Technology Business Overview
  88. 7.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  90. 7.15.5 Shenzhen Ruihan Medical Technology Recent Developments
  91. 7.16 Siyi Intelligence
  92. 7.16.1 Siyi Intelligence Company Information
  93. 7.16.2 Siyi Intelligence Business Overview
  94. 7.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  96. 7.16.5 Siyi Intelligence Recent Developments
8 North America
  1. 8.1 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  2. 8.1.1 North America Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 8.1.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 8.1.3 North America Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 8.2 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 8.2.1 North America Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 8.2.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 8.2.3 North America Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 8.3 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  10. 8.3.1 North America Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lower Extremity Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  2. 9.1.1 Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 9.1.3 Europe Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 9.2 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 9.2.1 Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 9.2.3 Europe Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 9.3 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  10. 9.3.1 Europe Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lower Extremity Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  2. 10.1.1 China Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 10.1.2 China Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 10.1.3 China Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 10.2 China Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 10.2.1 China Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 10.2.2 China Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 10.2.3 China Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  2. 11.1.1 Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 11.1.3 Asia Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 11.2 Asia Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 11.2.1 Asia Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 11.2.3 Asia Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 11.3 Asia Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  10. 11.3.1 Asia Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lower Extremity Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  2. 12.1.1 SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 12.2 SAMEA Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 12.2.1 SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 12.3 SAMEA Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  10. 12.3.1 SAMEA Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lower Extremity Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
  2. 13.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lower Extremity Exoskeleton Enhancement Device Production Mode & Process
  6. 13.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
  9. 13.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.